Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,428.00    38.00 (1.59%)
Bid:
2,428.00
Ask:
2,430.00
Spread: 2.00 (0.082%)
Market Cap: £7.80b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Trading Statement

14 Dec 2023 07:00

RNS Number : 6937W
Bunzl PLC
14 December 2023
Β 

14 December 2023

BUNZL PRE-CLOSE STATEMENT

2023 PROFIT OUTLOOK UPGRADED; THREE FURTHER ACQUISITIONS ANNOUNCED

Β 

Bunzl plc, the specialist international distribution and services Group, is updating the market today prior to entering its closed period for the year ending 31 December 2023.

Β 

Following the Group's strong performance over recent years, Bunzl expects to deliver another set of good annual results, with adjusted operating profit expected to be slightly ahead of prior guidance. Group revenue in 2023 is expected to be broadly in line with 2022, at constant exchange rates and excluding the impact of the disposal of our UK healthcare business. Within this, revenue growth from acquisitions is expected to be offset by the expected underlying revenue decline, reflective of lower Covid-19 related sales, reducing inflation benefit and wider post-pandemic related normalisation trends, particularly in North America. Inclusive of the disposal of our UK healthcare business, total Group revenue in 2023 is expected to be 1 to 2% lower than in 2022, at constant exchange rates, and with currency over the year expected to have minimal impact. Group adjusted operating profit is expected to deliver moderate growth, with operating margin expected to be slightly ahead of the previous record level.

Β 

Looking ahead, despite uncertainties relating to the wider economic and geopolitical landscape, the Group expects some revenue growth in 2024, at constant exchange rates, driven by announced acquisitions and slightly positive organic growth. Group operating margin is expected to be broadly in-line with 2023, and to remain substantially higher compared to pre-pandemic levels, driven by the higher margin acquisitions acquired since then, as well as an underlying margin increase.

Β 

In November 2023, Bunzl completed the acquisition of Melbourne Cleaning Supplies, a distributor of cleaning & hygiene supplies in Australia which expands our customer proposition and complements our existing business. In 2022, the business generated revenue of AUD 18 million (c.Β£10 million).

Β 

In addition, Bunzl completed the acquisition of Flexpost in November 2023, a higher margin distributor of flexible signposts and bollards in North America with a strong own brand portfolio. Flexpost generated revenue of USD 4 million (c.Β£3 million) in 2022 and follows other recent acquisitions focused on asset protection solutions.

Β 

In December, Bunzl completed the acquisition of Miracle Sanitation Supply, a leading cleaning & hygiene distributor in the Canadian province of Manitoba which strengthens Bunzl's presence in the region. The business generated CAD 11 million revenue in 2022 (c.Β£7 million).

Β 

Bunzl also completed the previously announced acquisitions of Safety First and Grupo Lanlimp in November, and of CT Group in December, which generated combined revenue of Β£97 million in 2022.

Β 

Commenting on today's announcement, Frank van Zanten, Chief Executive Officer of Bunzl, said:

Β 

"I'm pleased with the performance Bunzl has delivered this year, reflecting the dedicated efforts of our people in supporting our customers around the world. The Group is on track to deliver moderate adjusted operating profit growth, supported by a record operating margin, and we are guiding to further growth in 2024, continuing to build on the strong performance we have seen over recent years. Furthermore, we welcome three new complementary businesses to the Group today, taking the total acquisitions announced this year to 17. Over the last four years we have committed a cumulative c.Β£1.7bn to acquisitions, reflecting a step-up in our spend, and with our pipeline remaining active and supported by our strong balance sheet."

Β 

Enquiries:

Β 

Bunzl plc

Frank van Zanten, Chief Executive Officer

Richard Howes, Chief Financial Officer

Sunita Entwisle, Head of Investor Relations

Tel: +44 (0)20 7725 5000

Teneo

Martin Robinson

Olivia Peters

Tel: +44 (0)20 7353 4200

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTBLBDDCDBDGXX
Date   Source Headline
3rd Jun 202610:45 amRNSDirector/PDMR Shareholding
1st Jun 202610:15 amRNSTotal Voting Rights
1st Jun 202610:00 amRNSAdmission to Trading
8th May 20264:13 pmRNSDirector/PDMR Shareholding
7th May 20262:43 pmRNSDirector/PDMR Shareholding
6th May 202610:05 amRNSDirector/PDMR Shareholding
1st May 202611:15 amRNSTotal Voting Rights
22nd Apr 20264:15 pmRNSResult of AGM
22nd Apr 20267:00 amRNSTrading Statement
13th Apr 20264:00 pmRNSDirector/PDMR Shareholding
9th Apr 202612:01 pmRNSDirector/PDMR Shareholding
1st Apr 20264:00 pmRNSDirector/PDMR Shareholding
1st Apr 202611:00 amRNSTotal Voting Rights
31st Mar 20264:50 pmRNSDirector/PDMR Shareholding
20th Mar 20262:28 pmRNSDirector/PDMR Shareholding
18th Mar 20265:26 pmRNSDirector/PDMR Shareholding
17th Mar 20264:20 pmRNSAnnual Financial Report
16th Mar 20263:00 pmRNSDirector/PDMR Shareholding
16th Mar 20263:00 pmRNSDirector/PDMR Shareholding
11th Mar 20264:00 pmRNSDirector/PDMR Shareholding
11th Mar 20264:00 pmRNSDirector/PDMR Shareholding
10th Mar 20263:30 pmRNSDirector Declaration
10th Mar 20263:30 pmRNSDirector Declaration
9th Mar 202610:20 amRNSDirector/PDMR Shareholding
5th Mar 20265:15 pmRNSDirector/PDMR Shareholding
4th Mar 20264:00 pmRNSDirector/PDMR Shareholding
3rd Mar 20264:45 pmRNSDirector/PDMR Shareholding
2nd Mar 202611:00 amRNSTotal Voting Rights
2nd Mar 202610:00 amRNSDividend Declaration
2nd Mar 20267:00 amRNSFinal Results
3rd Feb 20265:00 pmRNSDirector/PDMR Shareholding
2nd Feb 202612:45 pmRNSTotal Voting Rights
13th Jan 20265:00 pmRNSDirector/PDMR Shareholding
7th Jan 20265:15 pmRNSDirector/PDMR Shareholding
6th Jan 202611:15 amRNSDirector/PDMR Shareholding
2nd Jan 202610:45 amRNSTotal Voting Rights
17th Dec 20257:00 amRNSTrading Statement
3rd Dec 202512:00 pmRNSDirector/PDMR Shareholding
1st Dec 202511:00 amRNSTotal Voting Rights
27th Nov 20259:00 amRNSAdditional Listing
26th Nov 20253:34 pmRNSPublication of Admission Particulars.
21st Nov 20255:30 pmRNSHolding(s) in Company
17th Nov 20255:34 pmRNSHolding(s) in Company
13th Nov 20259:00 amRNSAdditional Listing
5th Nov 20259:45 amRNSDirector/PDMR Shareholding
3rd Nov 20254:00 pmRNSHolding(s) in Company
3rd Nov 20253:29 pmRNSTotal Voting Rights
3rd Nov 20259:30 amRNSBlock listing Interim Review
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.